KPV is the tripeptide lysine–proline–valine, commonly studied as a short fragment related to alpha-melanocyte-stimulating hormone signaling.
Also known as kpv
Current picks · Nov 14, 2026
KPV picks by exact product.
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
2 of 4 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: KPV COAs →
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
Last reported low
$0.72/mg
Last reported median
$4.67/mg
Vendor coverage at last point
91
Last historical observation
Sep 19, 2026
━ Market low┄ Market medianUSD per mg · includes recorded discounts
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
View the last reported point of each month
KPV · source-reported historical market summaries, last point of each month
Date
Low /mg
Median /mg
Vendors
Offers
$0.72
$4.67
91
117
$0.80
$4.90
85
108
$1.89
$4.50
55
73
$0.45
$4.50
31
48
What it is
A plain-language overview.
KPV is a three-amino-acid sequence. The exact short name is difficult to resolve reliably in broad chemical indexes, so this entry relies on matched research records and keeps identity claims narrow.
Research evidencepreclinical or mixed
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
What has been studied.
Indexed experimental work includes inflammation, gastrointestinal delivery, skin-cell stress, and immune-signaling questions. The bounded search did not find a matched registered clinical-study record, so the current evidence label remains preclinical or mixed.
KPV is commonly sold or discussed for immune response and inflammation research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.
Vendor directory
KPV across 68 vendors.
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.